Bruce J. Wendel's most recent trade in ImmunityBio Inc was a trade of 146,020 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ImmunityBio Inc | Bruce J. Wendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 146,020 | 146,020 | - | - | Stock Option (right to buy) | |
| GT Biopharma Inc | Bruce J. Wendel | Director | 27 Jan 2023 | 500,000 | 500,000 | - | - | Option to purchase Common Stock | ||
| GT Biopharma Inc | Bruce J. Wendel | Director | 15 Jul 2022 | 50,000 | 50,000 | - | - | Option to purchase Common Stock | ||
| GT Biopharma Inc | Bruce J. Wendel | Director | 15 Jul 2022 | 50,000 | 50,000 | - | - | Option to purchase Common Stock |